Andrew D. Campbell

1 ta ish

AstraZeneca (United Kingdom)

1. Discovery of <i>N</i>-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1<i>H</i>-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors

   Jason G. Kettle, Rana Anjum, Evan Barry +24

   Maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.003421